Clinical Trials Browser

Interventional × Fractures, Spontaneous × Plasma cell × Clear all

Bone Neoplasms, Femoral Fractures, Fractures, Spontaneous, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Sarcoma

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

Clinical Trials

Dalteparin in Preventing DVT in Participants With Cancer

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma